Protection of SPF Chickens by H9N2 Y439 and G1 Lineage Vaccine against Homologous and Heterologous Viruses
Vaccines · 24.02.2023 · 11 (3) · 538
DOI: 10.3390/vaccines11030538 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 24.02.2023. Verfasst von Hyun-Kyu Cho und 7 weiteren Autor:innen. Beteiligte Einrichtung: Avian Influenza Research & Diagnostic Division, Animal and Plant Quarantine Agency, 177 Hyeoksin 8-ro, Gimcheon-si 39660, Republic of Korea. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Animal and Plant Quarantine Agency, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea.
Abstract (Originalsprache)
Prior to the identification of low pathogenic avian influenza H9N2 viruses belonging to the Y280 lineage in 2020, Y439 lineage viruses had been circulating in the Republic of Korea since 1996. Here, we developed a whole inactivated vaccine (vac564) by multiple passage of Y439 lineage viruses and then evaluated immunogenicity and protective efficacy in specific-pathogen-free chickens. We found that LBM564 could be produced at high yield in eggs (108.4EID50/0.1 mL; 1024 hemagglutinin units) and was immunogenic (8.0 ± 1.2 log2) in chickens. The vaccine showed 100% inhibition of virus in the cecal tonsil with no viral shedding detected in either oropharyngeal or cloacal swabs after challenge with homologous virus. However, it did not induce effective protection against challenge with heterologous virus. An imported commercial G1 lineage vaccine inhibited viral replication against Y280 and Y439 lineage viruses in major tissues, although viral shedding in oropharyngeal and cloacal swabs was observed up until 5 dpi after exposure to both challenge viruses. These results suggest that a single vaccination with vac564 could elicit immune responses, showing it to be capable of protecting chickens against the Y439 lineage virus. Thus, our results suggest the need to prepare suitable vaccines for use against newly emerging and re-emerging H9N2 viruses.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Avian Influenza Research & Diagnostic Division, Animal and Plant Quarantine Agency, 177 Hyeoksin 8-ro, Gimcheon-si 39660, Republic of Korea.
- Bioapp Institute, 394 Jigok-ro, Pohang-si 37668, Republic of Korea.
ORCID-Profile: Yong-Myung Kang, Mingeun Sagong
Förderung
- Animal and Plant Quarantine Agency
- Ministry of Agriculture, Food and Rural Affairs, Republic of Korea
Zitieren
APA
Cho, H. K., Kang, Y. M., Sagong, M., Kim, J., Kim, H., An, S., Lee, Y. J., & Kang, H. M. (2023). Protection of SPF Chickens by H9N2 Y439 and G1 Lineage Vaccine against Homologous and Heterologous Viruses. Vaccines, 11(3), 538. https://doi.org/10.3390/vaccines11030538
Vancouver
Cho HK, Kang YM, Sagong M, Kim J, Kim H, An S, et al. Protection of SPF Chickens by H9N2 Y439 and G1 Lineage Vaccine against Homologous and Heterologous Viruses. Vaccines. 2023;11(3):538. doi:10.3390/vaccines11030538
BibTeX
@article{Cho2023,
author = {Cho, Hyun-Kyu and Kang, Yong-Myung and Sagong, Mingeun and Kim, Juhun and Kim, Hyunjun and An, Sungjun and Lee, Youn-Jeong and Kang, Hyun-Mi},
title = {Protection of SPF Chickens by H9N2 Y439 and G1 Lineage Vaccine against Homologous and Heterologous Viruses},
journal = {Vaccines},
year = {2023},
volume = {11},
number = {3},
pages = {538},
doi = {10.3390/vaccines11030538}
}
EUVIMED